Insider Transactions in Q2 2021 at Eagle Pharmaceuticals, Inc. (EGRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 08
2021
|
Steven B Ratoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,020
+8.59%
|
$49,140
$7.33 P/Share
|
|
Apr 01
2021
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
16,278
-1.04%
|
$667,398
$41.87 P/Share
|
|
Apr 01
2021
|
Scott Tarriff |
BUY
Exercise of conversion of derivative security
|
Direct |
31,201
+1.96%
|
$249,608
$8.78 P/Share
|